ZWZoe Freeman Weiss

Zoe Freeman Weiss

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zoe Freeman Weiss has a total of 106 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Redesigning Microbiology Order Architecture to Improve Laboratory Efficiency

    by Justin McCallum, Lance Harlan, Beverley Orr, Karen Krajewski, Eliezer Nussbaum, Sankha Basu, Zoe Freeman Weiss

    Background: Clinical microbiology culture interpretation depends on accurate specimen context, including specimen type, anatomic source, and collection method. However, electronic ordering systems often permit nonspecific culture orders that do not capture the information needed for appropriate processing, reporting, and result interpretation. Methods: We performed a quality improvement intervention at an academic tertiary care center to replace a generic “aerobic culture” order with specimen-specific wound, sterile body fluid, and tissue/biopsy culture orders linked to required specimen type and anatomic source fields. Ordering pathways were harmonized across procedural and nonprocedural work flows, and available tests were constrained based on the selected specimen type and source. Results: Before intervention, 1115 of 2528 eligible culture orders required laboratory cancellation and reordering, compared with 78 of 508 eligible orders after implementation, 44.1% vs 15.4%, risk ratio 0.35, 95% CI 0.28–0.43, P < 0.001. Generic aerobic culture ordering declined to zero 5 months after residual ordering pathways were identified and corrected. Remaining errors were largely attributable to retained preference-list orders, previously placed future or standing orders, and gaps in clinician education. Conclusions: Specimen-specific microbiology order design reduced preanalytical ordering error and laboratory rework. These findings support microbiology order architecture as a practical diagnostic stewardship strategy that can improve specimen-context capture, reduce downstream laboratory correction, and better align culture ordering with laboratory processing requirements.

  • Open Access

    Ebola laboratory preparedness at frontline hospitals: can we or can’t we?

    by Nicholas E. Heger, Elyse Fritschel, Eliezer Nussbaum, Hunter Fraker, Justin McCallum, Beverley Orr, Robert Skahan, Elaine Minchello, Melissa Backman, Monika Pilichowska, et al.

    Frontline hospitals are required to care for patients with suspected viral hemorrhagic fever (VHF), yet guidance on laboratory preparedness remains fragmented and incomplete. We conducted a multidisciplinary risk assessment of our institutional capacity to perform routine diagnostic testing for VHF persons under investigation (PUI), focusing on the feasibility of using automated core laboratory instruments. Our assessment revealed substantial gaps between CDC guidance (which permits core lab testing) and the practical ability to implement it safely. Public health mandates for VHF preparedness have not been accompanied by granular guidance on biosafety, laboratory infrastructure, or regulatory clarity necessary for implementation. Community hospitals, which would benefit most from safely using their existing automated core laboratory instruments, lack the infrastructure, staffing expertise, and clear guidance to do so, while well-resourced tertiary centers are often best positioned to develop dedicated point-of-care testing (POCT)-based workflows. Federal and state authorities must provide explicit, validated examples of acceptable mitigation strategies for testing using core lab instrumentation and reconcile conflicting recommendations across guidance documents. Without such authoritative clarity, frontline hospitals cannot confidently meet their mandated VHF preparedness obligations.


  • Open Access

    Point-Counterpoint: The “obsoletogram”—are annual hospital antibiograms still relevant?

    by Zoe Freeman Weiss, Sankha S. Basu

    Annual hospital antibiograms, cumulative reports of antimicrobial susceptibility data from clinical isolates, are widely used to guide empiric antibiotic therapy, monitor resistance trends, and support antimicrobial stewardship. Most hospital antibiograms are compiled annually from clinical bacterial isolates, using the first isolate per patient and species. Although antibiograms have long proven their value, some now question whether traditional versions still meet modern clinical needs, given the need for personalized medical decision-making and emerging new diagnostic technologies that can provide faster, actionable results. In the following point-counterpoint article, the limitations of traditional antibiograms and the view that they may no longer be adequate for contemporary surveillance or decision-making are contrasted with the reasons antibiograms may remain essential and how they can evolve to stay relevant in modern healthcare.


  • Open Access

    Caution against using plasma mNGS for NHSN CLABSI surveillance

    by Zoe F. Weiss, Eliezer Zachary Nussbaum, Bhavarth Shukla, Shira Doron, Kap Sum Foong

  • Open Access

    Evaluation of omadacycline in vitro activity against Corynebacterium species

    by Saltanat Ualiyeva, Justin McCallum, Alexander Donald Pyden, Zoe Freeman Weiss

    Corynebacterium spp. are gram-positive bacteria increasingly recognized as pathogens. This study evaluates the MICs of omadacycline, a tetracycline, against 40 clinical Corynebacterium isolates using two methodologies: broth microdilution (BMD) and Liofilchem omadacycline MIC Test Strip (MTS). By BMD, the MIC 50 , MIC 90 , and MIC range were 0.5 µg/mL, 1 µg/mL, and 0.12–2.0 µg/mL, respectively. Comparing BMD to MTS, essential agreement (EA, within ±1 doubling dilution of the reference BMD MIC) was 87.5% (95% CI: 73.0%–95.4%).


  • Open Access

    Delving into discrepancies, a single-center experience with Accelerate Pheno for gram-negative bacteremia, a rapid phenotypic susceptibility testing method

    by Zoe Freeman Weiss, Dimitar Zelenkov, Jon Englert, Maureen Campion

    Objective: Discrepancies or inaccuracies between testing methods can create confusion or lead to clinical harm if antibiotics are inappropriately chosen. We report our clinical experience using the Accelerate Pheno™ followed by routine automated susceptibilities by the Vitek®2 for positive blood cultures with gram-negative rods. Design: This was a retrospective review of positive gram-negative blood cultures, including comparison of susceptibility testing results and impact on clinical care. Setting: Academic teaching hospital. Patients (participants): All patients admitted to the hospital with gram-negative bacteremia from January 2020 to December 2022. Methods: Microbiology was reviewed for discrepancies as defined by very major errors (VMEs), major errors (MEs), and minor errors (mEs). Clinical charts were reviewed for antibiotic therapy. Results: Positive blood cultures with gram-negative rods were included (n = 262). Between these two methods, overall essential agreement was 93.7% (2162/2304) and categorical agreement 93.5% (2159/2306). There were 147 discrepancies noted, including 6 VMEs, 25 MEs, and 116 mEs accounting for 96 patients. Antibiotic choice was changed in 8 patients due to perceived suboptimal empiric therapy based on the rapid susceptibility results. Conclusions: The Accelerate Pheno tended to over-call resistance compared to the Vitek®2. Few patients (8) received the incorrect antibiotic based on the Pheno result. Stewardship programs may choose to optimize their rapid antibiotic susceptibility testing reporting to help minimize confusion and guide appropriate antibiotic selection.


  • Open Access

    Invasive gastrointestinal aspergillosis in an ICU patient with perforated diverticulitis: risk factors and management challenges

    by Ahmad Hamdan, Thomas Howe, Fabiola Reyes, Zoe Weiss

    An immunocompetent man in his 60s was treated in the emergency department with prednisone and doxycycline for suspected contact dermatitis and superimposed cellulitis. Two days later, he returned with abdominal pain, scrotal swelling, and progressive rash. Imaging revealed perforated diverticulitis extending into the right testicle. He was managed with broad-spectrum antibiotics and underwent an exploratory laparotomy. An elevated serum galactomannan level was noted but deemed clinically insignificant, as he was not considered a typical host for an invasive mold infection. He required additional surgeries, with pathology eventually showing necrosis and fungal hyphae consistent with Aspergillus species infiltrating the small bowel with associated angioinvasion. He was started on combination antifungal therapy with voriconazole and micafungin, followed by liposomal amphotericin B. The patient ultimately died from invasive gastrointestinal aspergillosis (IGIA). This case report explores the risk factors, clinical course, and treatment of IGIA in an intensive care unit patient who was otherwise immunocompetent.

  • Open Access

    Duped by dumping syndrome: Non-Endemic Vibrio cholerae bacteremia in an immunocompetent host with gastric bypass surgery, a case report

    by Fabiola Reyes, Nicole Pecora, Zoe F Weiss

    Extra-intestinal infection with non-O1/non-O139 strains of Vibrio cholerae (NOVC) is rare, though bacteremia and hepatobiliary manifestations have been reported. Reduced stomach acid, or hypochlorhydria, can increase risk of V. cholerae infection. We describe a 42-year-old woman with hypochlorhydria due to untreated Helicobacter pylori infection, gastric-bypass surgery, and chronic proton pump inhibitors (PPI) exposure, who developed acute diarrhea following raw oyster consumption. Her symptoms were attributed to rapid gastric emptying (dumping syndrome) after a negative limited stool work-up. She had persistent diarrhea, weight loss, and after five months was admitted with acute cholecystitis and NOVC bacteremia, requiring cholecystectomy. This is the first reported case of NOVC bacteremia and cholecystitis in a patient with gastric bypass. This case highlights the potential for NOVC biliary carriage, the role of hypochlorhydria as a risk factor for Vibrio infection, and the importance of excluding infectious diarrhea in patients with new onset of symptoms compatible with dumping syndrome and a relevant travel history.